-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Anika Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2010 to 2023.
- Anika Therapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $27.2M, a 16.6% decline year-over-year.
- Anika Therapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $180M, a 41% increase year-over-year.
- Anika Therapeutics, Inc. annual Costs and Expenses for 2023 was $191M, a 68.8% increase from 2022.
- Anika Therapeutics, Inc. annual Costs and Expenses for 2022 was $113M, a 40.6% increase from 2021.
- Anika Therapeutics, Inc. annual Costs and Expenses for 2021 was $80.3M, a 17.5% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)